Surgery or Meds for Weight Regain After Sleeve Gastrectomy?
A study comparing conversion surgery and medication therapy for weight regain after sleeve gastrectomy found that surgery leads to greater weight loss. One-anastomosis gastric bypass showed the most significant results, with higher total weight loss and better resolution of type 2 diabetes and hypertension. The research highlights the effectiveness of surgical options over pharmacological treatments for patients experiencing recurrent weight gain.
- ▪Conversion surgery, particularly one-anastomosis gastric bypass, delivers greater and more durable weight loss than medication therapy.
- ▪Among 195 participants, those who underwent one-anastomosis gastric bypass had a mean total weight loss of 25.8%.
- ▪Resolution rates of type 2 diabetes and hypertension were significantly higher in the surgery groups compared to the medication group.
Medscape files mainly under health. We currently carry 231 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Medscape |
| Canonical URL | https://www.medscape.com/viewarticle/surgery-or-meds-weight-regain-after-sleeve-gastrectomy-2026a1000iex?src=rss |
| Publication time | Tue, 2 Jun 2026 22:45:37 EDT |
| Retrieval time | 2026-06-03T03:11:49.579Z |
| Last seen | 2026-06-03T03:11:49.579Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | jXtSlSKpblHq |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
TOPLINE:Conversion surgery, particularly one-anastomosis gastric bypass, delivers greater and more durable weight loss than medication therapy in patients with recurrent weight gain after sleeve gastrectomy.METHODOLOGY:Sleeve gastrectomy carries a notable risk for recurrent weight gain that may require revisional conversion to Roux-en-Y gastric bypass or one-anastomosis gastric bypass, procedures that are more complex than obesity medication therapy with agents such as GLP-1 receptor agonists.Researchers conducted a retrospective analysis of a prospectively maintained registry at a tertiary university hospital in Tel Aviv, Israel, to compare long-term outcomes with obesity management medications vs conversion surgery in patients treated for recurrent weight gain after sleeve gastrectomy…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
